Benchling has 6 close competitors: Kry (Livi), Neuralink, Pristyn Care.
Sector, valuation and status for each competitor.
company profile›
competitor›
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
BenchlingKry (Livi)NeuralinkPristyn CareSignosSolugenAbridgeThe AI Scientist connects predictive models, structured data, and wet lab execution into a single loop. It designs experiments, routes lab automation or guides manual execution, captures results as st
Benchling competes with 6 companies here: Kry (Livi), Neuralink, Pristyn Care, Signos, Solugen, Abridge.
Benchling was last valued at $6.1B (Nov 2021). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The last valuation is $6.1B.
Lead investors for each round are in the funding timeline.
The closest biotech/research software peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Benchling is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
